omeprazole has been researched along with Hyperparathyroidism, Secondary in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient was also treated with omeprazole (20 mg/day) because of chronic gastritis." | 3.73 | Gastric pH, sevelamer hydrochloride and omeprazole. ( Capitanini, A; Del Corso, C; Gallieni, M; Lupi, A; Osteri, F; Petrone, I; Rossi, A; Straniti, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capitanini, A | 1 |
| Lupi, A | 1 |
| Osteri, F | 1 |
| Petrone, I | 1 |
| Del Corso, C | 1 |
| Straniti, M | 1 |
| Gallieni, M | 1 |
| Rossi, A | 1 |
1 other study available for omeprazole and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Gastric pH, sevelamer hydrochloride and omeprazole.
Topics: Adult; Anti-Ulcer Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Interactions; Fema | 2005 |